Dr. Miller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
102 Endicott St
Danvers, MA 01923Phone+1 978-882-6060
Summary
- Dr. Adam Miller is an oncologist in Danvers, MA and is affiliated with multiple hospitals in the area, including Massachusetts General Hospital and North Shore Medical Center. He received his medical degree from Indiana University School of Medicine and has been in practice 3 years. He specializes in thoracic cancer.
Education & Training
- Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2016 - 2018
- Indiana University School of MedicineResidency, Internal Medicine, 2013 - 2016
- Indiana University School of MedicineClass of 2013
Certifications & Licensure
- MA State Medical License 2018 - 2026
- NH State Medical License 2024 - 2024
- IN State Medical License 2016 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsA Phase II Trial of Atezolizumab Plus Carboplatin Plus Pemetrexed Plus Bevacizumab in the Treatment of Patients with Stage IV Non-Squamous Non-Small Cell Lung Cancer: ...Fatemeh Ardeshir-Larijani, Sandra K Althouse, Ticiana Leal, Lawrence Eric Feldman, Taher Abu Hejleh
Clinical Lung Cancer. 2022-11-01 - 6 citationsCoronavirus Disease 2019 Infection in a Patient Population with Lung Cancer: Incidence, Presentation, and Alternative Diagnostic ConsiderationsAndrew J. Piper-Vallillo, Meghan J. Mooradian, Catherine B. Meador, Beow Y. Yeap, Jennifer L Peterson
JTO Clinical and Research Reports. 2021-01-01 - 17 citationsAssociation Between Immune-Related Adverse Events and Clinical Outcomes to Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Blockade in SCLC.Biagio Ricciuti, Abdul Rafeh Naqash, Jarushka Naidoo, Kartik Sehgal, Adam Miller
JTO Clinical and Research Reports. 2020-11-01
Press Mentions
- MicroRNA-155 Contributes to Plexiform Neurofibroma Growth Downstream of MEKDecember 8th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: